Eight genes (NKX6-2, A2BP1, CA10, DBC1, MYO3A, NPTX2, PENK, and SOX11) were significantly highly methylated in the urine sediments of bladder cancer patients as compared to that of control subjects. This evidence concerns the gene MYO3A and urinary bladder cancer.